Point72 Hong Kong LTD Sesen Bio, Inc. Transaction History

Point72 Hong Kong LTD

  • $1.54 Billion
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$0.77 - $4.91 $63 - $402
-82 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$2.18 - $4.66 $178 - $382
82 New
82 $0

Others Institutions Holding SESN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Sesen Bio, Inc.

SESN Quotes by TradingView
  • Ticker SESN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,702,000
  • Market Cap $127M
  • Description
  • Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...
More about SESN
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email